Suppr超能文献

新型羟基吡啶类抗真菌剂利罗吡司的体外抗真菌活性

[In vitro antifungal activity of rilopirox, a new hydroxypyridone antimycotic agent].

作者信息

Harada I, Mitsui K, Uchida K, Yamaguchi H

机构信息

Teikyo University Institute of Medical Mycology.

出版信息

Jpn J Antibiot. 1997 Feb;50(2):195-9.

PMID:9100079
Abstract

In vitro antifungal activities of rilopirox (RIL), a new topical hydroxypyridone antifungal agent, were studied against 7 species (31 strains) of yeast-like fungi and 15 species (17 strains) of mycerial fungi from stock cultures of a wide range of medically important fungi. Tests were carried out by the liquid dilution method using Neopeptone dextrose broth with ciclopirox olamine (CPO) and oxiconazole nitrate (OCZ) as reference drugs. RIL exhibited a broad spectrum of antifungal activities; the MIC of RIL against yeasts were about 1 microgram/ml, those against other fungi were 0.5-4 micrograms/ml. Antifungal activities were similar to CPO, and compare to OCZ, RIL showed characteristically little differences in its activities against different species or strains of target organisms.

摘要

新型外用羟基吡啶酮类抗真菌药利洛吡司(RIL)对从多种具有重要医学意义真菌的保藏培养物中获取的7种(31株)酵母样真菌和15种(17株)丝状真菌进行了体外抗真菌活性研究。以环吡酮胺(CPO)和硝酸奥昔康唑(OCZ)作为参比药物,采用液体稀释法,在新胨葡萄糖肉汤中进行试验。RIL表现出广谱抗真菌活性;RIL对酵母的最低抑菌浓度约为1微克/毫升,对其他真菌的最低抑菌浓度为0.5 - 4微克/毫升。其抗真菌活性与CPO相似,与OCZ相比,RIL对不同种类或菌株的靶标生物的活性差异极小。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验